See also this year's filing and all EDGAR filings for this company.
PDF Report 0001516079_2019_US_China_Biomedical_Technology_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 2.837426794388705e-06, 'aggregate_val': 352433, 'exp_sum': 352432, 'exp_to_value': {'LiabilitiesCurrent': 27319, 'LiabilitiesNonCurrent': 0, 'remainder_Liabilities': 325113}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001516079, US China Biomedical Technology Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 61,407 |
| 1 | AssetsNonCurrent | 0 |
| 2 | IntangibleAssets | 0 |
| 3 | PropertyPlantAndEquipment | 0 |
| 4 | remainder_Assets | 19,219 |
| 5 | LiabilitiesCurrent | 27,319 |
| 6 | LiabilitiesNonCurrent | 0 |
| 7 | remainder_Liabilities | 325,114 |
| 8 | CostOfGoodsAndServicesSold | 0 |
| 9 | SellingAndMarketingExpense | 0 |
| 10 | GeneralAndAdministrativeExpense | 0 |
| 11 | remainder_Expenses | 906 |
| 12 | remainder_Revenues | 0 |
| 13 | remainder_NetIncome | -481,258 |
| 14 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 80,626 |
| 1 | Liabilities | 352,433 |
| 2 | Expenses | 906 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -271,807 |
| 5 | NetIncome | -482,164 |
| 6 | ComprehensiveNetIncome | -482,164 |
| 7 | BaseVar | 457,612 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.12 |
| 9 | EconomicCapitalRatio | 0.0247 |
Edgar->Model Mapping
Feature Distribution
Change over Time
